Metabolic Diseases

196 treatments and conditions followed through the public trial records. Not medical advice.How a status is set

Lists this condition and the narrower ones beneath it. A condition is not a diagnosis.

Treatments and conditions

Metabolic Diseases
Treatment and conditionWhere it standsTrials
AI-Guided Multimodal Rehabilitation Program for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Alcohol beverage for ketosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Aminohippurate Sodium Inj 20% + CANAGLIFLOZIN for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AP306 100 mg TID for hyperphosphatemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AP306 125 mg BID for hyperphosphatemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AP306 125 mg TID for hyperphosphatemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AP306 150 mg BID for hyperphosphatemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AP306 75 mg BID for hyperphosphatemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
AP306 75 mg TID for hyperphosphatemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ARBs in combination of SGLT2i for diabetes mellitusPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
ATR-258 for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Autoinjector + EVOLOCUMAB for hypercholesterolemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Autoinjector + EVOLOCUMAB for hyperlipoproteinemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Avexitide for glucose metabolism disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Avexitide for hypoglycemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
AZD6234 for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Barley beta-glucan(3.0g) for hyperlipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
BBI-001 for hemochromatosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
BEAM-301: Single dose of BEAM-301 administered by IV for glycogen storage disease type iPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Berberine ursodeoxycholate for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Berobenatide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Beta glucan for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Body Composition + Blood Draw + CGM/CKM + gradCPT + Ketogenic Diet + Ketone/Glucose Monitoring + NIH Toolbox + PHQ-9 + Resting-state fMRI + SKID + Sleep Monitoring + Task-fMRI + WHO-5 for ketosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bread with added beta-glucans for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bread with added beta-glucans for hyperglycemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Bread with added beta-glucans for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Cagrilintide for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Calorie restricted diet and exercise intervention for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Calorie restriction via total food replacement for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
cfMSC therapy for diabetes for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
cfMSC therapy for diabetes for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CIL001 (Paliroden) for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Clazakizumab for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Clofutriben for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Continous Glucose Monitor (CGM) + Low-calorie diet + Personalized exercise program for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Control for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Control for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CoolSculpting® System for lipid metabolism disordersTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for homozygous familial hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
CTX310 for hyperlipoproteinemia type vPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Culturally Tailored Diabetes Prevention Program for prediabetic statePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Culturally Tailored Diabetes Prevention Program + Culturally Tailored DPP Enhanced with Socioeconomic Supports for prediabetic statePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Danuglipron for diabetes mellitusPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin + Elecoglipron for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dapagliflozin propanediol for iron deficienciesTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
delayed APM group recruit participants with symptoms lasting for more than 6 months for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Dexcom G6 Professional Continuous Glucose Monitor + INSULIN HUMAN for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexcom G6 Professional Continuous Glucose Monitor + Sliding Scale Insulin for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Dexcom G6 Professional Continuous Glucose Monitor + Up-Titration of Home Insulin for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Diet-as-Usual (DAU) + LCHF Ketogenic Diet for ketosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Diet-as-Usual (DAU) + LCHF Ketogenic Diet for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Digital Intervention + Metformin for prediabetic statePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
digital prosthetic interface technology for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
DMR Procedure for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
DMR Procedure (Fractyl) for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
DR10624 Injection for hypertriglyceridemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)2
Dulaglutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Early arthroscopic partial menisectomy group for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Echocardiography + Electrocardiogram (ECG) + DEFERIPRONE + Deferoxamine + Deferasirox for iron overloadPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Efzimfotase Alfa for hypophosphatasiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Elecoglipron for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Eloralintide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Eloralintide for metabolic diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Eloralintide + Macupatide for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Eloralintide + Tirzepatide for metabolic diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
eloralintide and tirzepatide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Empagliflozin for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Empagliflozin for ketosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide for hypercholesterolemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide for hyperlipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide Chloride for hypercholesterolemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Enlicitide Decanoate for hypercholesterolemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)6
Enlicitide Decanoate for hyperlipoproteinemia type iiPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Evolocumab for hypercholesterolemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)4
Exercise for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Exercise for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Exploratory test group for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ezetimibe or ezetimibe-statin combination therapy for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ezetimibe or ezetimibe-statin combination therapy for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
fecal microbiota transplantation from healthy lean donors for metabolic syndromeTrials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Fixed-Dose Combination Strategy for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Fixed-Dose Combination Strategy for dyslipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Food Security Screening & Referral Program for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Food-based diet for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Formula diet for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Green coffee + beta-glucan for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Green coffee extract for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
GVHD prophylaxis regimen + RIC regimen for metabolic diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Haploidentical Hematopoietic Cell Transplantation for metabolic diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
HD-6277 100mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
HD-6277 25mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
HD-6277 50mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
High-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
High-intensity Mediterranean diet intervention for hyperlipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
High-intensity Mediterranean diet intervention for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
HS-20094 Injection for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Hyperpolarized 13C-pyruvate for metabolic syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
icovamenib 100 mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
icovamenib 100mg for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Inclisiran for hyperlipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Insulin efsitora alfa for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)12
Insulin efsitora alfa for insulin resistancePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Intensified medical follow-up and glucose-lowering drugs for prediabetic stateTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intensive lifestyle Intervention for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intensive lifestyle Intervention + Meal replacement system for diabetes mellitus, type 2Trials ended early, as of 19 Nov 2026 (not yet checked by a person)1
Intermittent energy restriction (IER) for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Intermittent fasting 5:2 + Low-carbohydrate diet + Total diet replacement for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
K-757 and K-833 for diabetes mellitus, type 2Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
K-757 and K-833 BID + K-757 and K-833 QD for diabetes mellitus, type 2Phase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Kenetik for ketosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet for ketosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic Diet for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Ketogenic diet intervention for ketosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Laroprovstat for dyslipidemiasPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
LCHF Ketogenic Diet for ketosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
libitum diet and waiting list control group for metabolic syndromeTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Liraglutide for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-calorie MIND-HK diet for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Low-dose LC-Z300-01 twice daily in blinding for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Macupatide for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MAR001 for hypertriglyceridemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Maridebart Cafraglutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Meglumine sodium succinate for diabetic ketoacidosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Metreleptin for insulin resistancePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
MiniMed 670G system for hypoglycemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
MKP10241 for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
mRNA-3927 for acidosisPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
mRNA-3927 for propionic acidemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Napazimone for mitochondrial diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Neovasculgen® for diabetes mellitusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
obicetrapib 10 mg + ezetimibe 10 mg FDC daily for hyperlipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Olezarsen for hyperlipoproteinemia type iPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Oral appliance therapy for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Orforglipron for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)15
Osilodrostat for adrenal hyperplasia, congenitalPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Oxytocin for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Participants will receive Tongmai Jiangtang Capsule (TJC) in addition to standard treatment. for metabolic syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Patiromer for hyperkalemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PF-08653944 for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
PG-102 for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Phase 1 Dose Level 1 + Phase 1 Dose Level 2 + Phase 1 Dose Level 3 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Established Dose from prior study, NCT03810196 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phase 2 Maximum Tolerated Dose determined in Phase 1 for metabolism, inborn errorsPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Phentermine / Topiramate Oral Product for glucose intolerancePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
PolyPill for hyperlipidemiasTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Relacorilant for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Relacorilant for insulin resistanceTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for diabetes mellitusPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)10
Retatrutide for insulin resistancePhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Retatrutide for metabolic diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
RP-A501 for lysosomal storage diseasesPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for diabetes mellitusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)7
Semaglutide for glucose intolerancePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Semaglutide for prediabetic statePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Semaglutide + Cagrilintide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Sernova Cell Pouch for hypoglycemiaPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
SHR-1918 for homozygous familial hypercholesterolemiaTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Sodium zirconium cyclosilicate for hyperkalemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Structured weight-loss program for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Survodutide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Test group for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tifeglipron for diabetes mellitus, type 2Phase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Time Restricted Eating (TRE) for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Time Restricted Eating As Treatment (TREAT) for Diabetes. for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Time restricted feeding for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Time-restricted eating for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for diabetes mellitusPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)5
Tirzepatide for dyslipidemiasPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for metabolic diseasesPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Tirzepatide for metabolic syndromePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)2
Tirzepatide for prediabetic statePhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)3
Topical Simvastatin 2% Cream for xanthomatosisTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
Total Diet Replacement for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Total Diet Replacement (800kcal/day) for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Total Diet Replacement (TDR) Program for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Tranexamic acid for iron deficienciesPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Treatment with Ketone Supplement for ketosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Treatment with Placebo for ketosisPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
Treosulfan for nijmegen breakage syndromePhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for hypercholesterolemiaPhase 2 trial, as of 19 Nov 2026 (not yet checked by a person)1
VERVE-102 for hyperlipoproteinemia type iiPhase 1 trial, as of 19 Nov 2026 (not yet checked by a person)1
Very Low-calorie MIND-HK diet for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Vicadrostat for diabetes mellitus, type 2Phase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Vitamin D supplementation for diabetes mellitusTrial registered, as of 19 Nov 2026 (not yet checked by a person)1
VX-017 for hypoglycemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
WS016 for hyperkalemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1
Zenagamtide for diabetes mellitus, type 2Trial registered, as of 19 Nov 2026 (not yet checked by a person)1
Zimislecel for hypoglycemiaPhase 3 trial, as of 19 Nov 2026 (not yet checked by a person)1